Pediatrix® Medical Group Releases Inaugural Sustainability Report – InsuranceNewsNet


Report outlines the group’s ESG dedication, imaginative and prescient and technique

“Our governance construction underscores our dedication to compliance with relevant native, federal and state legal guidelines, guidelines and rules,” mentioned Dana Dreher-Rodwell, Vice President, Chief Compliance Officer and ESG Committee Co-chair. “Our ESG program is designed to permit us to conduct enterprise in compliance with moral requirements and integrity and demonstrates our dedication to our stakeholders.”

To view the report, please go to www.pediatrix.com/sustainability.

About Pediatrix Medical Group, Inc.

Pediatrix® Medical Group, Inc. (NYSE:MD) is the nation’s main supplier of doctor companies. Pediatrix-affiliated clinicians are dedicated to offering coordinated, compassionate and clinically wonderful companies to ladies, infants and kids throughout the continuum of care, each in hospital settings and office-based practices. Specialties embody obstetrics, maternal-fetal drugs and neonatology complemented by greater than 20 pediatric subspecialties, in addition to a newly expanded space of pediatric main and pressing care clinics. The group’s high-quality, evidence-based care is bolstered by vital investments in analysis, schooling, quality-improvement and security initiatives. The physician-led firm was based in 1979 as a single neonatology observe and in the present day gives its extremely specialised and sometimes crucial care companies by way of greater than 4,800 affiliated physicians and different clinicians in 37 states and Puerto Rico. To study extra about Pediatrix, go to www.pediatrix.com or observe us on Fb, Instagram, LinkedIn, Twitter and the Pediatrix weblog. Funding data might be discovered at www.pediatrix.com/buyers.

Sure statements and data on this press launch and the sustainability report referenced herein could also be deemed to include forward-looking statements inside the that means of the Personal Securities Litigation Reform Act of 1995, Part 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Part 21E of the Securities Change Act of 1934, as amended. Ahead-looking statements could embody, however should not restricted to, statements regarding our goals, plans, initiatives, projections, objectives, commitments, expectations and methods, and all statements, aside from statements of historic info, that tackle actions, occasions or developments that we intend, count on, challenge, imagine or anticipate will or could happen sooner or later are forward-looking statements. These statements are sometimes characterised by terminology similar to “imagine,” “hope,” “could,” “anticipate,” “ought to,” “intend,” “plan,” “will,” “count on,” “estimate,” “challenge,” “positioned,” “technique” and related expressions, and are primarily based on assumptions and assessments made by the Firm’s administration in mild of their expertise and their notion of historic developments, present situations, anticipated future developments and different elements they imagine to be acceptable. Any forward-looking statements on this press launch are made as of the date hereof, and the Firm undertakes no responsibility to replace or revise any such statements, whether or not because of new data, future occasions or in any other case. Ahead-looking statements should not ensures of future efficiency and are topic to dangers and uncertainties. Vital elements that might trigger precise outcomes, developments, and enterprise choices to vary materially from forward-looking statements are described within the Firm’s most up-to-date Annual Report on Kind 10-Ok and its Quarterly Stories on Kind 10-Q, together with the sections entitled “Threat Elements”, as nicely the Firm’s present studies on Kind 8-Ok, filed with the Securities and Change Fee, and embody the impression of the Firm’s title change; the impression of the COVID-19 pandemic on the Firm and its monetary situation and outcomes of operations; the consequences of financial situations on the Firm’s enterprise; the consequences of the Inexpensive Care Act and potential modifications thereto or a repeal thereof; the Firm’s relationships with government-sponsored or funded healthcare applications, together with Medicare and Medicaid, and with managed care organizations and business medical health insurance payors; the impression of shock billing laws and its implementation; the Firm’s capability to adjust to the phrases of its debt financing preparations; the Firm’s transition to a third-party income cycle administration supplier; the impression of the divestiture of the Firm’s anesthesiology and radiology medical teams; the impression of administration transitions; the timing and contribution of future acquisitions; the consequences of share repurchases; the impacts of ESG applications on the Firm’s enterprise; and the consequences of the Firm’s transformation initiatives, together with its reorientation on, and progress technique for, its pediatrics and obstetrics enterprise.

src=”https://cts.businesswire.com/ct/CT?id=bwnewssty=20221201005273r1sid=acqr8distro=nxlang=en” model=”width:0;top:0″ />

Media Contact
Jennifer Gutierrez
Supervisor, Company Communications

954.384.0175 ext. 5684

[email protected]

Investor Relations Contact
Charles Lynch
Senior Vice President, Finance and Technique

954.384.0175 ext. 5692

[email protected]

Supply: Pediatrix Medical Group, Inc.





Source_link

Leave a Reply

Your email address will not be published. Required fields are marked *